The decision to receive boosters should be individualized. But you should discuss this with a physician that can help you objectively decide. You are also going to need to take recent infections into account when considering timing of boosters.
The data on redesigned boosters is hard to collect and process because the vaccine is being developed quickly and rightly so. You cannot extrapolate data on long Covid, etc. until data has been processed. It's disingenuous and bad science to confidently state the newest boosters will definitely do x or y. We can best guess based on past data but sometimes that turns out incorrect.
For example, Paxlovid's initial data suggested that not only would it reduce hospitalizations and chance of death but also possibly decrease viral shedding, reduce severity of symptoms and time of illness. With more data, the latter three didn't really pan out. And Paxlovid's strongest data are for those who are Covid naive, whether that is vaccinated or natural immunity. I have a longer conversation with patients and family than previously when considering Paxlovid for patients.